The husband of a woman who died days after a pediatric doctor discharged her has filed a lawsuit.
On August 19, 2016, Dahlia Salinas Tatman, then in her third trimester of pregnancy, was admitted to Sharp Memorial Hospital Mary Birch in Kearny Mesa after her obstetrician diagnosed Tatman with pre-eclampsia, a condition during pregnancy where blood-pressure levels are elevated.
Once admitted at Sharp Mary Birch, doctors prescribed Labetalol to reduce Tatman's blood pressure. On August 22, doctors performed an emergency cesarean section. Her blood pressure remained high.
Over the course of the next three days, Tatman's condition worsened. She described her pain as severe. Dr. Tina Ziainia, in charge of Tatman, upped the dosage of Labetalol in hopes the increased dosage would be effective. It wasn't. Ziainia then prescribed another high-blood-pressure medication, Nifedipine. The new medication slowly reduced Tatman's blood pressure. Ziainia then ordered Tatman's discharge.
On August 25, however, Tatman's blood pressure increased again. Tatman took another round of Nifedipine and her blood pressure dropped. Ziainia discharged Tatman the following day. According to the lawsuit, Tatman was sent home with the Labetalol and not the second prescription, which had positive results.
On August 27, while at home, Tatman began experiencing pain and high blood pressure. She took her medication but she soon lost consciousness. She returned to Sharp Mary Birch. Her blood pressure registered at 198 over 136. She slipped into a coma.
On August 30 she was taken off of life support and died. Tatman was 39 years old.
The lawsuit alleges that doctors should not have discharged Tatman for the sole reason that they had not been able to effectively manage her high blood pressure.
Reads the lawsuit, "[Tatman] was discharged from the hospital with uncontrolled high blood pressure and blood pressure medication that was ineffective in lowering and controlling her blood pressure readings into the acceptable range, which ultimately led to her death."
A spokesperson for Sharp Health Care declined to comment due to pending litigation.